Ling Huw - Concepedia

Concepedia

Author

Ling Huw

Gene Therapy Laboratory

Also Known As

Ling Huw, Ling Y. Huw

41

Publications

1.2K

Citations

7

H-Index

17

Concepts

All Affiliations

Gene Therapy Laboratory

LH

About

Ling Huw is an author at Gene Therapy Laboratory specializing in medicine, tumor biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	668
2	Cell Biology	2	2	668
3	Molecular Biology	1	1	66
4	Pharmacology	1	1	602
5	Cancer Cell Biology	1	1	66

Ling Huw

×

7

Publications

1.2K

Citations

7

H-Index

	Year	Citations
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Klaus W. Wagner, Elizabeth A. Punnoose, Thomas Januario, Nature Medicine Cancer ResearchG Protein-coupled ReceptorMedicineApoptosisCell Death	2007	602
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types Marie-Claire Wagle, Daniel C. Kirouac, Christiaan Klijn, npj Precision Oncology	2018	210
Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models Jill M. Spoerke, Carol O’Brien, Ling Huw, Clinical Cancer Research	2012	177
DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer Walter Kim, Thomas Holcomb, Tom Januario, Clinical Cancer Research	2012	86
Activating Mutations in <i>PIK3CB</i> Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β Yoshito Nakanishi, Kimberly Walter, Jill M. Spoerke, Cancer Research Molecular BiologyCancer BiologyTumor BiologySignaling PathwayReceptor Tyrosine Kinase	2016	66
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer Robert Piskol, Ling Huw, Ismail Sergin, Clinical Cancer Research	2019	53
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples Timothy R. Wilson, Yuanyuan Xiao, Jill M. Spoerke, Breast Cancer Research and Treatment	2014	25

Page 1